Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

46 results
Display

Transient elastography, true or false?

Seo YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Insight for HBV DNA and HBsAg Quantitation during Antiviral Therapy in Patients with Chronic Hepatitis B

Cho YK, Song BC

Over the past decade, advances in the antiviral therapy in patients with chronic hepatitis B have enabled the sustained suppression of hepatitis B viral replication and the prevention of progressive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors influencing the severity of acute viral hepatitis A

Kim JI, Kim YS, Jung YK, Kwon OS, Kim YS, Ku YS, Choi DJ, Kim JH

BACKGROUND/AIMS: Most patients with acute viral hepatitis A have a favorable course, but a few of them suffer from severe forms of hepatitis such as fulminant hepatitis. This study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Sweet's Syndrome in a Patient with Liver Cirrhosis Caused by Chronic Hepatitis B

Park CW, Kim YJ, Seo HJ, Lee KI, Jang BK, Hwang JS, Chung WJ

Sweet's syndrome (SS), also known as acute febrile neutrophilic dermatosis, is characterized by the sudden onset of painful erythematous skin lesions together with fever and neutrophilia. SS can be associated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B

Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY

BACKGROUND/AIMS: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Distribution of Hepatitis B Virus Genotypes according to the Clinical Outcomes in Patients with Chronic Hepatitis B Virus Infection in Jeju Island

Kim BJ, Song BC

  • KMID: 1066040
  • Korean J Gastroenterol.
  • 2003 Dec;42(6):496-501.
BACKGROUND/AIMS: The genotype of hepatitis B virus (HBV) has been suggested to correlate with the clinical outcome of HBV infection. We analyzed the distribution of HBV genotypes according to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Polymorphism in MicroRNA 604 with Susceptibility to Persistent Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma

Cheong JY, Shin HD, Cho SW, Kim YJ

MicroRNA polymorphisms may be associated with carcinogenesis or immunopathogenesis of infection. We evaluated whether the mircoRNA-604 (miR-604) polymorphism can affect the persistence of hepatitis B virus (HBV) infection, and the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New perspectives of biomarkers for the management of chronic hepatitis B

Lin CL, Kao JH

With recent advances in molecular and genomic investigations, the impact of hepatitis B viral and host factors on the progression of chronic HBV infection has been explored. For viral factors,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Castleman's Disease Mimicking a Hepatocellular Carcinoma: A Case Report and Review of Literature

Jang SY, Kim BH, Kim JH, Ha SH, Hwang JA, Yeon JW, Kim KH, Paik SY

Castleman's disease is a rare disease characterized by lymph node hyperplasia. Although Castleman's disease can occur wherever lymphoid tissue is found, it rarely appears in the abdominal cavity, and is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Qualitative Research Investigating Patterns of Health Care Behavior among Korean Patients with Chronic Hepatitis B

Yang JH, Cho MO, Lee HO

PURPOSE: This ethnograpy was done to explore patterns of health care behavior in patients with chronic health problems. METHODS: The participants were 15 patients with chronic hepatitis B and 2...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Jwa HY, Cho YK, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU, Kim BS, Lee BW, Song BC

Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver Stiffness Measurement for the Diagnosis of Hepatic Fibrosis in Patients with Chronic Viral Hepatitis

Kang JK, Cheong JY, Cho SW, Cho JH, Park JS, Kim YB, Kim DJ, Hwang SG, Yang JM, Park YN

BACKGROUND AND AIMS: FibroScan(R) is a new medical device that noninvasively measures liver stiffness. The aim of this study was to assess the accuracy of the liver stiffness measurement...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Meaning of the Emergence of Viral Breakthrough during Lamivudine Treatment in Patients with Hepatitis B Virus Related Chronic Liver Disease

Park CB, Lim HJ, Yun BC, Lee SU, Han BH

  • KMID: 760538
  • Korean J Hepatol.
  • 2004 Jun;10(2):108-116.
BACKGROUND/AIMS: Viral breakthrough has been considered a major limitation of lamivudine in the treatment of hepatitis B virus related chronic liver disease. Its clinical meaning has not been thoroughly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

Kim YJ, Kim K, Hwang SH, Kim SS, Lee D, Cheong JY, Cho SW

BACKGROUND/AIMS: Relapse has been reported after stopping nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy

Moon JC, Kim SH, Kim IH, Lee CH, Kim SW, Lee SO, Lee ST, Kim DG

BACKGROUND/AIMS: We investigated factors associated with the disease progression and development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients during long-term oral nucleos(t)ide analog (NA) therapy. METHODS: This retrospective...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Ha JM, Sohn W, Cho JY, Pyo JH, Choi K, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Paik YH

BACKGROUND/AIMS: Hepatitis-B-related acute-on-chronic liver failure has a poor prognosis. However, the advent of potent oral antiviral agents means that some patients can now recover with medical treatment. We aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus

Lee HJ, Choi JW, Kim TN, Eun JR

Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Significance of Quantitation of HBV DNA in Serum: Comparison of the Branched-DNA Assay with the Second-Generation Digene Hybrid Capture Assay and Long-term Observation

Jun EJ, Han JY, Choi H, Chang UI, Lee TK, Kim YH, Kim JI, Park SH, Kim JK, Chung KW, Sun HS

  • KMID: 1123165
  • Korean J Hepatol.
  • 2002 Jun;8(2):157-166.
BACKGROUNDS/AIMS: Serum levels of hepatitis B virus (HBV) DNA are direct measures of viral replication in hepatocytes. We compared branched-DNA assay (QuantiplexTM, bDNA) and Hybridization Capture II (HCII), and evaluated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naive patients with chronic hepatitis B infection

Chung WG, Kim HJ, Choe YG, Seok HS, Chon CW, Cho YK, Kim BI, Koh YY

BACKGROUND/AIMS: The aim of this study was to analyze the clinical impacts of obesity and hazardous alcohol use on the outcome of entecavir (ETV) therapy in chronic hepatitis B (CHB)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr